Investing in Healthcare

I just got accepted to my school's student-run investment fund to cover healthcare stocks, everything from pharma to med tech to hospitals etc.

I am actually interested in healthcare in the long term as well, and wanted to know if anyone had tips or resources for how to invest in this industry. I realize healthcare is really a catch-all term rather than industry so it can be tough to cover everything under healthcare.

Thanks

 

Pick a specific part of the industry, rather than focus on all aspects. Learn everything about that part of the industry. Figure out what the ACA will mean to it. This isn't super specific, but hopefully it will help keep you from trying to boil the ocean.

 

Agree with TechBanking. I think HC is probably one of the hardest industries to cover due to medical technicals for pharma and biomed/ devices. However, it is also one of the most interesting and fun to cover.

Last year at my internship, I covered a distressed pharma company and since such a large portion of their revenues rely on current and future patents/approvals, you will be learning a lot about substitute drugs and compounds which can get pretty technical (I haven't taken a bio class since HS), but is highly interesting.

"History doesn't repeat itself, but it does rhyme."
 
Best Response

All comments here have given some great information.

I agree that you want to figure out where you will focus, since different parts of healthcare have different levels of risk. You have clinical and FDA risk on the lifesciences / biopharma side, and you have various political factors affecting the services side. In the lifesciences world, there are established companies like ILMN who have significant product traction but room for additional upside through their pipeline products and growth in existing markets. In addition, many of the larger pharma companies are seeking growth through acquiring smaller biotech companies that are complementary to their existing product lines.

There are also much smaller companies that are still waiting for approval on their first product. Some people find these types of opportunities interesting, since you can profit heavily if the drug gets approved. Of course, the downside here is that you are taking binary risk, since an unfavorable FDA decision will tank the stock. I personally am too risk averse for these types of opportunities, but if you can develop an informed thesis as to why a certain drug will gain approval, or why the underlying technology may be of strategic interest to a large player, you can certainly earn a nice return.

To get yourself up to speed on the industry, I would recommend looking up the Deutsche Bank F.I.T.T. reports (I know they exist for various subverticals in services and biopharma). When I was in healthcare banking, these were helpful in learning about the industry. I also remember Piper Jaffray publishing some good material as well. You may have to go back a few years to find some of these, but they do a great job of explaining stuff in layman's terms. If I understood these without ever taking a biology class, I'm sure you will too

 

Dolor laudantium exercitationem impedit consequatur. Id maxime esse qui excepturi corporis qui cum minus. Iure velit iste odio id necessitatibus neque cumque quis. Sit sit provident ipsa et esse ipsam. Molestiae sit et consectetur praesentium aut omnis reiciendis. Consequatur aut dolores molestiae et sunt ducimus. Error fugiat perspiciatis quaerat sit dolores beatae explicabo et.

I'm on the pursuit of happiness and I know everything that shine ain't always gonna be gold. I'll be fine once I get it

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
kanon's picture
kanon
98.9
9
bolo up's picture
bolo up
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”